Neurology Billing Guidelines 2026: What Every Practice Needs to Know

Neurology billing guidelines are the payer rules that govern how neurological services get coded, documented, and paid: which CPT code fits the service performed, which ICD-10 diagnosis proves it was necessary, how technical and professional components split between the practice and the facility, how many units a test supports, and which services need approval before the patient is ever scheduled.

Neurology carries more of these rules than almost any other specialty. Its core services are time-based (long-term EEG, prolonged E/M), component-split (every neurodiagnostic study has a technical and a professional side), unit-driven (nerve conduction studies are coded by how many nerves you studied), and drug-heavy (Botox and MS biologics carry four-figure claims with prior authorization attached). Each of those structures is a place where revenue quietly leaks.

This guide covers the complete rulebook for 2026: what actually changed in the Medicare fee schedule, credentialing, E/M optimization, the full neurodiagnostic code families, injectables and infusions, ICD-10 specificity, modifiers, documentation, prior authorization, and how to fight the insurance claim denials neurology practices go through.

What Changed in 2026 Medicare Payment, and What It Means for Neurology

Start with what did not happen: the conversion factor did not fall. For 2026, Medicare pays under two conversion factors for the first time, $33.5675 for qualifying participants in advanced alternative payment models and $33.4009 for everyone else, increases of 3.77 and 3.26 percent over the 2025 factor of $32.35. Most neurologists fall under the non-QP factor. A temporary 2.5 percent congressional increase is built into 2026 only, so build 2027 projections without it.

The squeeze for neurology hides one layer down. A negative 2.5 percent efficiency adjustment now applies to the work values of most non-time-based services. E/M visits and telehealth-list codes are exempt, but diagnostic and procedure codes are not, which means nerve conduction studies, EEG interpretations, and evoked potentials absorbed work RVU reductions even as the conversion factor rose. The accurate 2026 picture for a neurology practice: office visits pay slightly more, neurodiagnostics are mixed to down, and the only way to know your practice’s net position is to run your top 20 codes through the CMS Physician Fee Schedule Lookup Tool against last year’s allowables.

Two operational consequences follow. First, Medicare Advantage plans do not adopt fee changes on Medicare’s schedule; some pay at prior-year rates for 60 to 180 days after a change, others adjust sooner, so the same code pays differently across your payer mix for much of the year. Active payer variance monitoring, comparing remittance advice line by line against contracted and expected rates, is how you catch the plans that quietly underpay through the transition. Second, MIPS holds at a 75-point performance threshold with the low-volume exclusion unchanged: bill Medicare $90,000 or less, or see 200 or fewer Medicare patients, or provide 200 or fewer covered services, and you are excluded from reporting entirely.

Telehealth is the last piece of the 2026 picture: the flexibilities are now permanent, including virtual direct supervision, synchronous visits bill standard E/M codes with modifier 95 and place of service 10 or 02, and the originating site facility fee rose to $31.85. For neurology this fits medication management, imaging review, and follow-ups where the hands-on exam is not the point of the visit.

Credentialing for Neurologists: Get Paid From Day One

Submitting claims before credentialing completes is the most expensive administrative mistake a new neurology practice makes, because most commercial carriers will not backdate. The sequence: obtain your Type 1 individual NPI and, for a group or corporation, the Type 2 organizational NPI; settle your legal structure before filing anything; complete and attest your CAQH ProView profile and re-attest every 120 days, since an expired attestation silently stalls every pending application; enroll with Medicare through PECOS (Form CMS-855I for individuals, CMS-855B plus CMS-855R for groups reassigning benefits), noting that Medicare alone permits retroactive billing to the date it received a processable application; then apply to commercial panels and track every application on a two-week follow-up cadence, because turnaround runs 60 to 180 days.

The neurology-specific wrinkle: if your practice bills the technical component of electrodiagnostic or EEG studies at a site that functions as a testing facility, verify whether your Medicare contractor requires enrollment as an Independent Diagnostic Testing Facility. IDTF status carries its own supervision, equipment, and technologist requirements, and billing technical components without required IDTF enrollment is a recoupment waiting to happen. Calendar re-credentialing for every payer at the two-to-three-year mark; a missed deadline converts weeks of clean claims into denials.

Practices that want the applications handled end to end can lean on professional provider credentialing services to shorten time to first reimbursement.

E/M Coding: Where Neurology Under-Bills

Since the 2021 guidelines, E/M levels follow medical decision making or total time, and neurology visits legitimately support higher levels more often than most specialties because the raw ingredients of MDM are built into the caseload: multiple chronic neurological conditions, prescription drug management, review of external imaging and records, and decisions carrying real morbidity. A visit that manages an epilepsy patient’s anticonvulsants, evaluates a new cognitive complaint, and reviews an outside MRI is not a level 3 encounter, and coding it as one because level 3 feels safe is how practices donate revenue back to payers, visit after visit.

Two disciplines make higher levels defensible rather than dangerous. Document the elements of MDM explicitly: name each problem addressed, each data source reviewed, and the risk of the management chosen. And when billing on time, record exact minutes and what the time was spent on; estimates and templated time statements do not survive audits. Prolonged services (99417 with 99205 or 99215) capture the genuinely long visits, and remember E/M codes are exempt from the 2026 efficiency adjustment, which makes accurate E/M leveling the single most protected revenue line in the practice this year.

Neurodiagnostic Coding: EEG, EMG, NCS, and Evoked Potentials

Neurodiagnostics are where neurology billing is won or lost. Four code families, each with its own structure, and one shared rule: every study needs an order, a supporting diagnosis under the payer’s coverage policy, and a distinct interpretation and report documented in its own section of the record.

Routine EEG (95816, 95819, 95822, 95812, 95813)

Routine EEG codes are selected by the patient’s state of consciousness for recordings of 20 to 40 minutes: 95816 awake and drowsy, 95819 awake and asleep, 95822 coma or sleep only. Past 40 minutes, duration takes over regardless of state: 95812 for 41 to 60 minutes, 95813 for 61 to 119 minutes. Hyperventilation and photic stimulation are included and never billed separately, and Medicare coverage policy expects a routine EEG on file before long-term monitoring is ordered.

Long-Term EEG Monitoring: The Fork That Decides Everything

The 2020 restructure split long-term EEG into technical and professional components. On the technical side, 95700 reports the setup, patient education, and takedown by the EEG technologist, once per recording period, and 95705 through 95716 report the technologist’s work by duration, video use, and monitoring level (unmonitored, intermittent, or continuous). Code the monitoring level that was actually performed; documentation that says continuous when the log shows intermittent checks is an audit finding, not a billing choice.

The professional component turns on one question: when was the interpretation performed?

• Daily reporting, physicians has real-time access. When diagnostic interpretations and reports are generated each day and the physician can access the data throughout the recording, use 95717 or 95718 (2 to 12 hours, reportable a maximum of once per entire service, either for a short study or the final partial increment of a longer one) and 95719 or 95720 (each increment of greater than 12 up to 26 hours, reported per 24-hour period, with report after each period).
• Retrospective summary after the study ends. When the entire professional interpretation happens after the recording is complete, use the summary codes once, selected by total duration: 95721/95722 for greater than 36 up to 60 hours, 95723/95724 for greater than 60 up to 84 hours, 95725/95726 for greater than 84 hours (odd numbers without video, even with video).

CPT is explicit about the boundary: do not report 95717 through 95720 for studies longer than 36 hours when the professional report is retroactively generated, even if separate daily reports are rendered after the recording completes. A three-week ambulatory study read at the end is one summary code, not twenty-one daily codes. Daily codes across a multi-day study are legitimate only when the daily reads genuinely happened day by day with documented access, which is standard in an epilepsy monitoring unit and rare in home ambulatory studies. Bill the workflow you ran and can prove from the technologist log and report timestamps, because duration and report-timing mismatches are the number one payer audit target in this family.

EMG and Nerve Conduction Studies (95860-95870, 95885-95887, 95907-95913)

When needle EMG is performed alone, use the standalone codes 95860 through 95864 by number of extremities, 95867 and 95868 for cranial-nerve-supplied muscles, 95869 for thoracic paraspinals, and 95870 for limited studies of other muscles. When EMG is performed with nerve conduction studies on the same day, the EMG converts to an add-on: code the NCS first (95907 through 95913, selected by the total number of conduction studies performed, from 1 or 2 studies up to 13 or more), then add 95885 for limited needle EMG, 95886 for complete needle EMG (five or more muscles studied, innervated by three or more nerves or four or more spinal levels), or 95887 for non-extremity muscles.

Unit discipline decides whether these claims survive. Payer coverage policies cap how many conduction studies are reasonable per diagnosis, following norms published by the electrodiagnostic professional societies; a carpal tunnel workup billed at 95913 will be flagged on volume alone. Use LT and RT where the study is unilateral, append modifier 25 to a same-day E/M only when the visit was genuinely separate from the decision to test, and make sure the number of studies in the report arithmetic matches the code billed, because the mismatch is the most common EMG/NCS denial there is.

Evoked Potentials and the Add-On Codes Practices Forget

Somatosensory evoked potentials report with 95925 and 95926 (upper and lower limbs individually) or 95938 for both, each carrying the same interpretation-and-report requirement as EEG. The quieter revenue leak is add-on capture generally: needle EMG add-ons alongside NCS, 96020 for neurofunctional testing with physician oversight, and prolonged service codes on long visits. These go unbilled not because coders reject them but because charge capture workflows never prompt for them; fix the superbill and encounter templates once and the add-ons recover themselves on every eligible encounter afterward.

Technical vs Professional Components: Modifiers 26 and TC

Every neurodiagnostic code contains a technical component (the equipment, supplies, and technologist work) and a professional component (the interpretation). Bill globally, with no modifier, only when your practice owns both sides in an office setting. When the hospital or an IDTF owns the equipment, the neurologist bills the interpretation with modifier 26 and the facility bills TC. Splitting this wrong in either direction produces either an instant denial or an overpayment you will refund later with interest, and it is the mechanical reason the same CPT code pays a few dozen dollars in one setting and a few hundred in another.

Botox and Injectables: High-Value Claims, High Scrutiny

Chemodenervation for chronic migraine reports 64615, which describes the full bilateral injection protocol of the head and neck muscles; the code is inherently bilateral, so never add modifier 50. Cervical dystonia reports 64616. The drug itself bills separately as J0585 per unit of onabotulinumtoxinA, and since the units are the expensive half of the claim, two rules protect them: report discarded drug with modifier JW on a separate line, and report JZ when there was no wastage, because the JW/JZ attestation is mandatory on single-dose vial drugs and its absence is now an automatic edit.

Prior authorization on Botox is nearly universal with commercial and Medicare Advantage plans, typically requiring documented chronic migraine (15 or more headache days monthly), failed preventive medication trials, and headache diaries. Traditional Medicare generally does not impose prior authorization for office-administered Part B Botox, which is exactly the kind of payer-by-payer difference that belongs in your authorization work list rather than in staff memory. Buy-and-bill economics apply: the practice purchases the drug, so a denied claim is not lost revenue but negative revenue, and no injection should happen before the authorization number is on file.

Infusion Billing for MS Biologics

Neurology infusion suites bill two layers: administration and drug. Administration reports 96365 for the first hour of therapeutic infusion and 96366 for each additional hour, though several payers classify monoclonal antibody infusions under the complex biologic administration codes instead, so verify the required administration family per payer before the first claim, not after the first denial. The drugs bill as J-codes with unit precision, ocrelizumab as J2350 and natalizumab as J2323 among the common ones, with the same JW/JZ wastage rules as Botox.

Two policies decide the economics. Prior authorization is effectively universal, often paired with site-of-care requirements that steer patients away from hospital outpatient settings. And the buy-and-bill versus specialty pharmacy decision determines who carries the drug cost risk: buy-and-bill captures the drug margin but exposes the practice to five-figure losses on a single denied or underdosed claim, while white-bagged drugs remove the risk and the margin together. Whichever model you run, reconcile drug units administered against units billed on every remittance, because unit underpayment on J-codes is among the least visible leaks in neurology revenue.

Neurology ICD-10 Codes: Specificity Is the Whole Game

Neurology diagnoses carry structured axes the claim depends on: type, intractability, status, and laterality. Unspecified codes are the leading soft cause of medical necessity denials because coverage policies key on the specific children, not the category heads.

New and revised ICD-10 codes take effect every October 1 and CPT changes every January 1; re-verify your top 25 diagnosis codes each October, because superseded codes reject at the clearinghouse before a payer ever sees them.

Modifiers in Neurology Billing

Documentation: What the Record Must Prove

A billed neurological exam needs its elements in the note: mental status, cranial nerves, motor strength, sensory examination, reflexes, coordination, and gait as relevant to the visit. A line reading ‘neuro exam normal’ supports nothing. Time-based services need exact minutes, not estimates, and long-term EEG needs the technologist log and report timestamps to match the duration and report-timing codes billed, because that reconciliation is precisely what an auditor performs.

Two real audit outcomes show the stakes. A physician so far behind on documentation that encounters had no notes at all refunded every dollar those encounters had paid; no note, no service, no defense. Another billed every visit at level 5 with notes that could not support the level, and the department repaid Medicare. The rule both cases teach: record what you did, at the time you did it, at the level the record can prove.

Prior Authorization in Neurology

The neurology authorization list is short and expensive: Botox and other chemo denervation, biologic infusions, deep brain stimulation and other neurostimulators, advanced imaging under many Medicare Advantage and commercial plans, and elective epilepsy monitoring unit admissions. Build authorization into scheduling so the number is on file before the patient sits down, and remember two payment realities: authorization time itself is never billable to any payer, and physicians report spending roughly a dozen hours per week on authorization work in AMA survey data, which is exactly the administrative load practices weigh when deciding what to keep in-house.

Condition Spotlight: Parkinson’s Disease Across the Codebook

A Parkinson’s patient touches more code families than almost any other neurology encounter. Diagnosis uses the expanded G20 children (G20.A1 through G20.C), coded for the presence of dyskinesia and OFF fluctuations, and payers now expect that specificity. Office visits report 99202 through 99215 by complexity, and Parkinson’s visits are routinely moderate-to-high MDM given multi-drug management. DaTscan imaging reports 78803 (SPECT) or 78830 (SPECT-CT) plus HCPCS A9584 for the ioflupane tracer. Deep brain stimulation reports 61885 for a single electrode array and 61886 for two or more, with device programming under the 95970 to 95984 analysis-and-programming family, 95983 and 95984 for brain neurostimulator programming by time. Therapy layers add 97112 neuromuscular re-education, 97116 gait training, and 97530 therapeutic activities, and speech-language pathology adds 92507 for treatment and 92526 for swallowing dysfunction.

Condition Spotlight: Epilepsy and the Medical Necessity Chain

Epilepsy billing runs on a sequence payers enforce: a routine EEG establishes the baseline (Medicare coverage policy expects ambulatory monitoring to be preceded by a resting EEG), long-term monitoring escalates from there with the daily-versus-summary professional coding fork covered above, and EMU admissions sit behind prior authorization at most plans. Diagnosis specificity does the quiet work: intractability coding on the G40 family is what justifies extended monitoring, drug level management visits, and newer therapies, so an epilepsy panel coded to unspecified G40.909 is a practice pre-writing its own denials.

Why Neurology Claims Get Denied and How to Appeal

Every remittance names its own defect in Claim Adjustment Reason Codes and Remittance Advice Remark Codes, and a billing team that works denials by reason code recovers most of them. The denial drivers specific to neurology: NCS unit counts exceeding policy norms, long-term EEG duration or report-timing mismatches against the technologist log, missing or reversed 26/TC components, absent prior authorization on injectables and infusions, diagnosis codes too unspecific to satisfy the coverage policy behind a test, and eligibility gaps, particularly on Medicare Advantage plans mid-transition.

The appeal mechanics: Medicare’s first level is a redetermination filed within 120 days of the remittance date, with reconsideration and three further levels behind it, though neurology appeals almost always resolve in the first two. Commercial plans state the appeal window and address on the EOB, most commonly 180 days for first level. A winning neurology appeal packet is the claim, the remittance showing the reason code, the order and interpretation, the payer’s own policy language, and for neurodiagnostic the technologist log that proves duration and report timing; a one-page letter connects them. Work denials within a week of the remittance, scrub claims before submission rather than after rejection, and track first-pass acceptance (95 percent or better) and overall denial rate (single digits) monthly. When either drifts, the reason codes tell you which upstream process broke.

Services You Cannot Bill, No Matter How You Code Them

Prior authorization time is not billable to any payer. Informal phone calls and portal messages that fall short of the structured digital E/M thresholds (99421 through 99423, patient-initiated, cumulative over seven days) are considered part of the surrounding visits; time on them can inform the next visit’s level when documented, but never double-count the same minutes. And any code carrying no relative value units, including many Category III codes for emerging technology, pays nothing unless a specific payer policy says otherwise, so confirm coverage in writing before building a service line on one. Where Medicare does not cover a service the patient wants anyway, a signed Advance Beneficiary Notice before the service is what converts it from a write-off into patient responsibility.

Neurology Billing FAQs

What is the 2026 Medicare conversion factor?

There are two for the first time: $33.5675 for qualifying alternative payment model participants and $33.4009 for all other clinicians, up 3.77 and 3.26 percent from 2025’s $32.35. A 2.5 percent efficiency adjustment separately reduced work values on most non-time-based services, so individual neurodiagnostic codes may still pay less than last year.

What is the difference between 95719 and 95721?

95719 is a daily code, reported per 24-hour period when the physician generates a report each day with real-time access to the data. 95721 is a summary code, reported once for a complete study of greater than 36 up to 60 hours when the interpretation happens after the recording ends. The report timing, not the study length alone, decides which family applies.

How many nerve conduction studies can you bill per encounter?

Codes 95907 through 95913 scale by total studies performed, up to 13 or more, but payer coverage policies cap what is reasonable per diagnosis based on professional society norms. The count in the report must match the code billed, and routine mononeuropathy workups billed at the top codes are flagged on volume alone.

Does Medicare require prior authorization for Botox for chronic migraine?

Traditional Medicare generally does not for office-administered Part B Botox, while Medicare Advantage and commercial plans nearly always do, typically requiring documented chronic migraine and failed preventive trials. Verify per plan before purchasing drug.

Why are neurology claims denied more often than other specialties?

The specialty concentrates the structures that generate denials: unit-count rules on NCS, duration and report-timing rules on long-term EEG, technical and professional component splits on every study, prior authorization on high-cost drugs, and coverage policies keyed to diagnosis specificity.

Can you bill for prior authorization time?

No. Medicare and commercial payers uniformly treat authorization work as non-billable administrative activity, which is why the roughly dozen weekly hours it consumes per physician belongs in the outsourcing math.

Why Neurology Practices Choose UControl Billing

Everything in this guide is work someone in your practice has to do correctly, every day: the daily-versus-summary fork on long-term EEG, unit counts on nerve conduction studies, JW and JZ attestations on every vial of Botox, component splits on every study, and payer variance that shifts underneath you for half the year. UControl Billing does this work for neurology practices as its core job, with AAPC and AHIMA certified coders who bill the monitoring workflow you actually ran, reconcile drug units on every remittance, and appeal denials with the technologist log attached.

If your current billing operation cannot tell you your first-pass acceptance rate, your denial rate by reason code, and your payer variance this quarter, that is the gap. Get a free neurology billing audit and see what your claims data says. Get Free Billing Audit

The Bottom Line

Neurology medical billing requires more than generic RCM. It requires fluency in technical versus professional components across EEG, EMG, and evoked potentials, time-based billing for long-term monitoring and prolonged E/M, bundling rules for multi-test encounters, documentation standards that survive audits, infusion billing for MS biologics, prior authorization for Botox, neurostimulators, and advanced imaging, and payer policies that shift throughout the year. A generic billing vendor is not failing you out of negligence; neurology is simply different. The practices that come out ahead in 2026 are the ones that level E/M accurately, capture their add-on codes, bill the monitoring workflow they actually ran, reconcile drug units on every remittance, and watch payer variance line by line.